MyOme, Inc. Sustainability Profile
MyOme, Inc., a pioneering force in the personalised genomics industry, is headquartered in the United States and operates across key regions globally. Founded in 2016, the company has rapidly established itself as a leader in genetic testing and analysis, focusing on empowering individuals with actionable insights into their health and wellness. MyOme's core offerings include advanced genomic testing services that provide comprehensive reports on health risks, carrier status, and drug responses. What sets MyOme apart is its commitment to delivering tailored genetic information that enhances patient care and informs lifestyle choices. With a strong emphasis on innovation, the company has achieved significant milestones, including partnerships with healthcare providers and research institutions, solidifying its position in the market as a trusted resource for personalised health solutions.
DitchCarbon Score
How does MyOme, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MyOme, Inc.'s score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MyOme, Inc.'s reported carbon emissions
MyOme, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data, as indicated by the absence of specific emissions figures. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that MyOme may not yet have established formal commitments to reduce carbon emissions or may not be disclosing such information publicly. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific commitments or emissions data, it is unclear how MyOme aligns with these industry standards. As the company progresses, it may consider setting measurable targets to enhance its climate strategy and transparency.
How Carbon Intensive is MyOme, Inc.'s Industry?
How Carbon Intensive is MyOme, Inc.'s Location?
MyOme, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MyOme, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
